Gynecologic Oncology · v0.2.0

Build the case as a clinical story

Site-first navigation, chronological case intake, medical-oncology decision drivers, RT/brachy workspace and point-of-use teaching.

PREVIEWExecutable systemic-therapy slices are source-bounded and require clinical review.

No patient identifiers. This preview does not save cases to WordPress. Use age band / clinical facts only. Source-bounded preview; clinical review required.

Loading the simple piano…

If this message remains, reload the page. JavaScript is required for this clinical preview.

CASE INTAKE

Tell the story in the order it happened

1Where are we in the story?This changes which later questions matter.

Clinical episode Age band Current clinical question

2How did the disease present?Start with the reason the patient entered the pathway.

Presentation / symptoms Index date / interval

3How was cancer confirmed?Pathology before treatment assumptions.

Histology Grade / differentiation Pathology certainty

Histology and grade determine which staging, molecular and treatment branches are even applicable.

4What is the extent of disease?Imaging, local extension, nodes, distant disease, then stage.

Local extent / key imaging Nodal disease Distant disease FIGO stage Imaging summary Resectability / oligometastatic context

Disease distribution and local feasibility

Nodal locationNodal burden / distributionDistant disease site(s)Distant disease burdenSurgical resectabilityDefinitive local-treatment feasibility

5What does the tumour biology add?Only decision-driving biomarkers appear for the selected site/episode.

6What has already happened?Surgery, RT/brachy and systemic therapy form a treatment timeline.

Prior surgery Prior pelvic RT / brachy Prior systemic therapy Last platinum / response interval Prior PARP inhibitor Prior bevacizumab Prior immune checkpoint inhibitor Best prior response / major toxicity Residual toxicity

7What is happening now?Current burden, tempo and symptoms—not historical stage alone.

Disease tempo Symptomatic disease Volume

8Can the proposed treatment be given safely?Recommendation is not prescription readiness.

Performance status Renal function Marrow reserve Hepatic function Major comorbidity / contraindication Fertility / pregnancy context

Clinical Safety handoffAny regimen remains NOT READY TO PRESCRIBE until drug-specific prerequisites, organ-function thresholds, overlapping toxicities and monitoring are checked.Open Clinical Safety

9What decision are we making today?The output should answer this question—not every possible question.

Intent Human decision checkpointDecision note

RADIOTHERAPY / BRACHYTHERAPY

EQD2 summation workspace

Custom calculation only in v0.1; no unsourced prescription presets or OAR constraints are encoded yet.

EBRT total dose (Gy) EBRT fractions Brachy dose / fraction (Gy) Brachy fractions

Tumour / acute α/β 10—

Late OAR α/β 3—

How is this calculated?

Linear-quadratic EQD2 = D × (d + α/β) / (2 + α/β), calculated separately for EBRT and brachytherapy and then summed for the selected α/β. Physical doses are never simply added as biologically equivalent doses.

Tell the story in the order it happened

EQD2 summation workspace

Add RT Navigator to your Home Screen

Install RT Navigator

Loading the simple piano…

Tell the story in the order it happened

EQD2 summation workspace

Teach me this case